Comments
Top court rejects two medical test patents
21.03.2012. | WASHINGTON (Reuters) - The Supreme Court rejected two patents on a method for monitoring a patient's blood to determine the best dosage for a drug, a decision that may affect the profitability of personalized medicine....
